GENE ONLINE|News &
Opinion
Blog

2025-08-19|

Study Identifies Gene Activity Linked to Nerve Cell Resistance in Hereditary ALS

by Mark Chiang
Share To

Researchers have identified specific gene activity that protects certain nerve cells from damage caused by amyotrophic lateral sclerosis (ALS), according to a study conducted by Stockholm University in collaboration with the Paris Brain Institute and Örebro University. The findings, published in *Genome Research*, focus on a hereditary form of ALS linked to mutations in the SOD1 gene. By analyzing millions of messenger RNA (mRNA) molecules over the progression of the disease, scientists uncovered why some nerve cells remain resistant while others are vulnerable to degeneration.

The study examined how mRNA molecules behave in both resilient and sensitive nerve cells affected by ALS. Researchers concentrated on understanding the mechanisms at play in this genetic form of ALS, which is caused by specific mutations in the SOD1 gene. Their analysis revealed distinct patterns of gene activity that appear to shield certain nerve cells from damage, offering new insights into cellular processes during disease progression. These findings may provide a foundation for further research into potential therapeutic strategies targeting these protective mechanisms.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: August 19, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
LATEST
Takeda R&D President Andy Plump and GV Managing Partner Krishna Yeshwant Announce Retirements
2026-09-12
Shine Spect USA Updates Clinical and Safety Guidelines for Xenon Xe-133 Gas
2026-09-11
Amorepacific Updates Hera Black Cushion Ingredient Disclosures for Ten Foundation Shades
2026-09-11
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
Record Investor Attendance at NLS Days 2026 Drives Nordic Life Science Dealmaking
2026-09-11
Disc Medicine and Silence Therapeutics Develop Polycythemia Vera Treatments to Compete With Takeda and Protagonist
2026-09-11
Leucine Supplementation Linked to Reduced Lymphoid Malignancy Growth and Improved Survival in Study
2026-09-11
Scroll to Top